deinstitutionalization movement. In Chapter 1, the authors position psychiatric rehabilitation as an integrated paradigm within the medical and therapeutic community, and social learning models. Chapter 2 deals with the evolution of the psychopathology of mental illness from the early psy chody namic explanations of mental illness to the latest neurobiologic developments. Chapter 3 presents the structure of clinical assessment, as well as the formulation and planning of rehabilitation interventions. The authors wisely insist on the importance of acknowledging clients' values and goals before engaging any rehabilitation or recovery process. The core notion of a clinical problem critical to the development of a rehabilitation plan is also developed in this chapter.
Chapter 4 details models of neurophysiological dysregulation in mental illness. In Chapters 5 and 6, the attractive concept of neurocognitive recovery is presented. It was also fascinating to learn about the interaction between neurobiologic parameters and psychosocial interventions, for example, the normalization of cortisol levels in individuals involved in psychiatric rehabilitation (1). Chapter 7 summarizes the different approaches to neurocognitive interventions. The benefit of the milieu as therapeutic environment per se is also acknowledged. The authors confirm that nonspecific rehabilitation factors, such as attendance and participation, can be conducive to neurocognitive recovery and exert beneficial effects on the course of the illness at any time. Two tables give readers practical clues on how to facilitate attention, learning, and memory in group skills training. Chapter 8 deals with social cognition or complex neurocognitive functions that are "social" (for example, perception of facial cues and voice tone). Is a skill only an ability to perform specific tasks? According to Spaulding and others, it has many other meanings, which they describe in Chapter 9. The next chapter focuses on person-environment interactions, especially the milieu that can be a support and a social learning tool. The authors reaffirm that human values, scientific understanding, and technical solutions should all contribute to the development of effective rehabilitation plans.
The last part of the book focuses on the implementation and management of a rehabilitation program. Chapter 11 explains the diverse roles that rehabilitation team members (that is, case managers, skills trainers, milieu coordinators, and psychopharmacotherapists) have to play. Changes in functioning and environment demands call for periodic medication reevaluations, and the authors clearly see the physician in a central role requiring highly coordinated efforts to deliver effective pharmacologic treatments. The last chapter discusses how to practically run a rehabilitation program and is based on Spaulding's 20 years of rehabilitation practice. It especially underlines the role and duties of the program director. The issue of a program drift (that is, the gradual deviation from basic principles and procedures and how to remedy it) is also addressed here. Finally, the authors, being Americans, stress the importance of adapting the managed care model to rehabilitation interventions that benefit patients at the stable phase of their illness. In managed care, this is the time when the discontinuation of services for "medical stability" is achieved.
This book is a major work and clearly presents what psychiatric rehabilitation has to offer at its best. The authors have much experience and tremendous expertise in the field of rehabilitation. This book will serve as a core text for courses in psychiatric treatment and rehabilitation of those with severe mental illness. It summarizes the actual state of knowledge regarding this relatively new field of psychiatry. The text is well written in clear and practical language. Numerous footnotes define many concepts or semantic nuances, such as the difference between psychiatric and psychosocial rehabilitation.
The price is reasonable for the amount of knowledge it provides, and the text represents a good investment for those who treat patients with severe disabilities or who are interested in developing more rehabilitation interventions. 
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The cooccurrence of substance abuse and severe mental illness (which is how these authors define dual disorders) is a frequent problem in psychiatry and one that is associated with poorer outcome. Substance abuse has a strong impact on psychiatric illness: alcohol abuse increases the risk of suicide among depression, schizophrenia, and bipolar disorder patients; use of cannabis and other illicit drugs contributes to treatment resistance and poor adherence, as well as to many relapses and hospitalizations, in all major psychotic disorders. In the general population, the lifetime prevalence of substance abuse disorders (SAD) is 16.7%. However, among schizophrenia patients, it is 47%; among those with major depression, it is 27%; and among bipolar disorder patients, it is 56%. Of the SADs, alcohol abuse is the most common, followed by cannabis and cocaine abuse. Spontaneous remission without treatment is much rarer than in the general population.
The traditional approach is to treat first the primary disorder, then the secondary one. Sometimes, simultaneous treatment occurs (that is, parallel treatment by different clinics or agencies). Lack of coordination leads regularly to poor prognosis. Further, multimodal intervention is the rule: individual, group, and family approaches are integrated. The impact of each individual component is unknown, and it is somewhat frustrating to be left in doubt about the relative importance of each ingredient. My own guess would be that ACT, conducted long-term and within the spirit of MI, would probably be most significant in most cases.
In conclusion, the New Hampshire team proposes a program built over the past 2 decades, with fair empirical support for its superiority. How widely has it spread over the US, Canada, and elsewhere? I don't know the answer to this question, but my guess is that it has not been taken up as much as one would hope, for the following reasons: 1) psychiatrists in general, many of whom receive inadequate substance abuse training in their residency programs, have limited interest in this area; 2) in the US, the context of managed care is a factor; and 3) in Canada and Europe, the vagaries of financing the health care system are factors. These issues are not conducive to the major changes required by the proposed philosophy.
